Explain this page
Arphra AIPlain-English read on GE HealthCare Technologies Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.87% | +1.69% | +4.61% | -19.25% | -22.67% | -22.20% | -10.29% | -20.72% | +6.35% | +6.35% | +6.35% |
Aftermarket
LiveLast trade
$63.81
23 sh
Bid
$63.50
7 sh
Ask
$63.98
505 sh
Spread
$0.480
Sector & industry today
LiveSectors
- Technology+2.24%
- Utilities+1.75%
- Industrials+1.45%
- Healthcare+1.23%
- Real Estate+0.71%
- Energy+0.71%
- Basic Materials+0.12%
- Communication Services-0.51%
- Financial Services-0.55%
- Consumer Cyclical-0.63%
- Consumer Defensive-1.61%
Top industries (issuer's industry highlighted)
- Medical - Healthcare Information Services-3.05%
- Broadcasting+6.89%
- Oil & Gas Energy+4.23%
- Computer Hardware+4.09%
- Engineering & Construction+3.86%
- Software - Infrastructure+3.76%
- Financial - Capital Markets+3.44%
- Beverages - Non-Alcoholic-3.42%
- Semiconductors+3.32%
- Oil & Gas Drilling+3.28%
- Telecommunications Services-3.05%
- Investment - Banking & Investment Services+3.04%
Fair value
Football field →Weighted blend
$86.72
+35.90% vs spot
Recommendation
Strong Buy
20 of 21 methods
Method spread
10bull10bear
±5% threshold
Analyst PT consensus: $84.00 (+31.64%)
Total assets
$36.91B
Total debt
$10B
Cash & equiv
$4.51B
Operating CF
$1.99B
Free cash flow
$1.51B
Buybacks
-$200M
Analyst view
DB · price_targets + analyst_gradesConsensus target
$84.00
+31.97% upside
Low
$65.00
Median
$85.00
High
$105.00
Recent actions
0 ↑0 ↓8 hold
- May 01, 2026
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
News
DB · news_items- GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilitiesbusinesswire.com·Jun 04, 2026
- GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilitiesbusinesswire.com·Jun 04, 2026
- GE HealthCare Technologies Inc. (GEHC) Presents at Jefferies Global Healthcare Conference 2026 Transcriptseekingalpha.com·Jun 03, 2026
- GE HealthCare Technologies Inc. (GEHC) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.com·May 12, 2026
- GE HealthCare Expands SIGNA MR Portfolio With AI-Powered Toolszacks.com·May 12, 2026
- GE HealthCare next-gen SIGNA MR technology helps advance research discovery and translate innovation into clinical impactbusinesswire.com·May 11, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GE HealthCare Technologies Inc. - GEHCprnewswire.com·May 07, 2026
- Here's Why GE Healthcare Shares Slumped This Weekfool.com·May 02, 2026
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $5.13B | $389M | $0.85 |
| Q4 Dec 2025 | $4.67B | $184M | $0.38 |
| Q3 Sep 2025 | $5.14B | $446M | $0.98 |
| Q2 Jun 2025 | $5.01B | $486M | $1.06 |
| Q1 Mar 2025 | $4.78B | $564M | $1.23 |
| Q4 Dec 2024 | $5.32B | $720M | $1.57 |
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Hochman Rodney F director | Buy | 1,618 | $100.36K | May 12, 2026 |
Yang Watkin Phoebe L. director | Buy | 1,000 | $63.01K | May 08, 2026 |
Stromberg William J director | Buy | 1,000 | $61.69K | May 06, 2026 |
CULP H LAWRENCE JR director | Buy | 80,805 | $5M | May 06, 2026 |
SACCARO JAMES officer: Chief Financial Officer | Buy | 3,310 | $200.59K | May 01, 2026 |
Jimenez Frank R officer: GC & Corporate Secretary | Buy | 1,750 | $105.79K | Apr 30, 2026 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $20.63B | $2.76B | $2.08B | $4.55 | +10.10% |
| FY 2024 | $19.67B | $2.63B | $1.99B | $4.34 | +10.13% |
| FY 2023 | $19.55B | $2.44B | $1.57B | $3.02 | +8.02% |
| FY 2022 | $18.34B | $2.52B | $1.92B | $4.22 | +10.45% |
| FY 2021 | $17.59B | $2.8B | $2.25B | $4.90 | +12.78% |